Aetna Inc. (NYSE:AET) had its target price boosted by Jefferies Group LLC from $165.00 to $185.00 in a research report issued on Wednesday. The firm presently has a “hold” rating on the stock. Jefferies Group LLC’s price objective would suggest a potential upside of 8.80% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. BidaskClub downgraded Aetna from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a research note on Tuesday, July 4th. Argus reaffirmed a “buy” rating and issued a $185.00 price target (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Deutsche Bank AG boosted their price target on Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Finally, BMO Capital Markets started coverage on Aetna in a research note on Monday, October 16th. They issued a “market perform” rating and a $175.00 price target for the company. Nine research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. Aetna currently has an average rating of “Buy” and a consensus price target of $164.72.

Shares of Aetna (AET) traded up 0.46% during trading on Wednesday, hitting $170.81. 1,607,839 shares of the stock were exchanged. The company has a market cap of $56.73 billion, a P/E ratio of 37.92 and a beta of 0.53. The firm’s 50-day moving average is $159.75 and its 200 day moving average is $152.04. Aetna has a 1-year low of $104.59 and a 1-year high of $184.98.

Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating the Zacks’ consensus estimate of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. Aetna’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.07 earnings per share. Equities analysts forecast that Aetna will post $9.50 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://theolympiareport.com/2017/11/01/aetna-inc-aet-pt-raised-to-185-00-at-jefferies-group-llc.html.

In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

A number of large investors have recently made changes to their positions in AET. BlackRock Inc. grew its stake in Aetna by 3,374.9% in the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after purchasing an additional 29,828,390 shares during the period. FMR LLC grew its stake in Aetna by 73.8% in the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after purchasing an additional 5,833,567 shares during the period. Janus Henderson Group PLC grew its stake in Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after purchasing an additional 4,283,553 shares during the period. Capital World Investors grew its stake in Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. Finally, Vanguard Group Inc. grew its stake in Aetna by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after purchasing an additional 838,578 shares during the period. Hedge funds and other institutional investors own 89.45% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.